Atlas Trials

CiPA Phase 1 ECG Biomarker Validation Study

Clinical trial NCT03070470 · COMPLETED

Trial details

NCT number
NCT03070470
Sponsor
Food and Drug Administration (FDA)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug-induced QT ProlongationPharmacokineticsPharmacodynamics
Start date
2017-03-14
Primary completion
2017-06-26
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.